Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 5 studies | 23% ± 10% | |
oligodendrocyte | 4 studies | 24% ± 9% |
Insufficient scRNA-seq data for expression of MUSK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 97% | 109.49 | 349 / 359 | 12% | 0.29 | 33 / 286 |
lung | 97% | 141.66 | 563 / 578 | 8% | 0.20 | 94 / 1155 |
intestine | 97% | 195.00 | 941 / 966 | 4% | 0.22 | 21 / 527 |
esophagus | 90% | 79.63 | 1303 / 1445 | 9% | 0.15 | 17 / 183 |
muscle | 97% | 415.08 | 782 / 803 | 0% | 0 | 0 / 0 |
heart | 92% | 98.10 | 790 / 861 | 0% | 0 | 0 / 0 |
bladder | 76% | 200.05 | 16 / 21 | 2% | 0.04 | 10 / 504 |
blood vessel | 74% | 42.53 | 986 / 1335 | 0% | 0 | 0 / 0 |
skin | 56% | 58.81 | 1010 / 1809 | 2% | 0.05 | 10 / 472 |
thymus | 31% | 9.35 | 201 / 653 | 0% | 0.00 | 1 / 605 |
adrenal gland | 27% | 8.30 | 70 / 258 | 0% | 0.01 | 1 / 230 |
ovary | 26% | 7.82 | 46 / 180 | 0% | 0.01 | 1 / 430 |
breast | 21% | 6.40 | 96 / 459 | 1% | 0.03 | 12 / 1118 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.36 | 6 / 29 |
brain | 19% | 12.00 | 515 / 2642 | 1% | 0.07 | 6 / 705 |
prostate | 17% | 8.21 | 42 / 245 | 1% | 0.02 | 5 / 502 |
adipose | 14% | 3.72 | 165 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 7% | 1.94 | 22 / 328 | 6% | 0.11 | 11 / 178 |
uterus | 9% | 2.57 | 16 / 170 | 3% | 0.17 | 12 / 459 |
liver | 4% | 1.16 | 10 / 226 | 3% | 0.09 | 12 / 406 |
kidney | 4% | 1.56 | 4 / 89 | 0% | 0.00 | 1 / 901 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.06 | 2 / 45 |
spleen | 3% | 0.75 | 7 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.02 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071340 | Biological process | skeletal muscle acetylcholine-gated channel clustering |
GO_2000541 | Biological process | positive regulation of protein geranylgeranylation |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0007275 | Biological process | multicellular organism development |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0030154 | Biological process | cell differentiation |
GO_0007613 | Biological process | memory |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0008582 | Biological process | regulation of synaptic assembly at neuromuscular junction |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0017147 | Molecular function | Wnt-protein binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MUSK |
Protein name | receptor protein-tyrosine kinase (EC 2.7.10.1) Muscle associated receptor tyrosine kinase Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) |
Synonyms | |
Description | FUNCTION: Receptor tyrosine kinase which plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between the motor neuron and the skeletal muscle . Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces phosphorylation and activation of MUSK, the kinase of the complex. The activation of MUSK in myotubes regulates the formation of NMJs through the regulation of different processes including the specific expression of genes in subsynaptic nuclei, the reorganization of the actin cytoskeleton and the clustering of the acetylcholine receptors (AChR) in the postsynaptic membrane. May regulate AChR phosphorylation and clustering through activation of ABL1 and Src family kinases which in turn regulate MUSK. DVL1 and PAK1 that form a ternary complex with MUSK are also important for MUSK-dependent regulation of AChR clustering. May positively regulate Rho family GTPases through FNTA. Mediates the phosphorylation of FNTA which promotes prenylation, recruitment to membranes and activation of RAC1 a regulator of the actin cytoskeleton and of gene expression. Other effectors of the MUSK signaling include DNAJA3 which functions downstream of MUSK. May also play a role within the central nervous system by mediating cholinergic responses, synaptic plasticity and memory formation (By similarity). . |
Accessions | ENST00000416899.7 O15146 ENST00000374439.1 F6XAJ2 A0A087WSY1 ENST00000189978.10 [O15146-2] ENST00000374448.9 [O15146-1] |